Femasys Inc. (FEMY)

CIK 0001339005 · Healthcare · Medical Instruments & Supplies

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-08) · 99.1
Latest FY-2025 8-K (2026-03-31) · 99.1
Q3-2025 8-K (2025-11-14) · 99.1
Q2-2025 8-K (2025-08-08) · 99.1
Q1-2025 8-K (2025-05-08) · 99.1
FY-2024 8-K (2025-03-27) · 99.1
Q3-2024 8-K (2024-11-12) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1
Q1-2024 8-K (2024-05-09) · 99.1
FY-2023
FY-2023 8-K (2024-03-28) · 99.1
Q3-2023 8-K (2023-11-14) · 99.1
Q2-2023 8-K (2023-08-10) · 99.1
FY-2022
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
Audit Information
—
Statements
Balance Sheets
Balance Sheets (P)
Condensed Statements of Comprehensive Income (loss)
—
Statement of Stockholders' Equity
Statements of Comprehensive Loss
Statements of Cash Flows
Notes
Accrued Expenses
—
Cash and Cash Equivalents
Clinical Holdback
—
Commitments and Contingencies
Convertible Notes With Warrants
Convertible Notes With Warrants (november 2023 Financing)
Cybersecurity Risk Management and Strategy Disclosure
—
Equity Incentive Plans
—
Equity Incentive Plans and Warrants
—
Fair Value
Fair Value of Financial Instruments
Income Taxes
Insider Trading Arrangements
Inventories
—
Leases
—
Net Income (loss) Per Share Attributable To Common Stockholders
—
Net Loss Per Share Attributable To Common Stockholders
Notes Payable
Organization, Nature of Business, and Liquidity
Other Expense, Net
—
Other Income (expense), Net
—
Pay Vs Performance Disclosure
Related-party Transactions
Retirement Plan
—
Revenue Recognition
—
Segment Reporting
Stockholders' Equity
Subsequent Events
Summary of Significant Accounting Policies
—